Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500115384Phase 4Not yet recruiting
Phase 4, randomised trial of crisugabalin besilate in fibromyalgia (FM) (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: NRS pain score change at week 12. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500115384.